Author: IQ TIMES MEDIA

Like many first-time moms, Nathalia Marin Torres was excited when she found out she was pregnant last August, but she was also a bit nervous. The 33-year-old Colombia native didn’t click with her OB-GYN and felt like she needed more support navigating the health care system in the United States.“When you’re kind of far away from family and from your culture, it’s a little bit overwhelming,” Torres said.She was referred to Alexia Franco Pettersen, a Mexican American doula in Minneapolis. Pettersen is helping guide Torres through prenatal visits and preparing for postpartum. She’ll be there for the entirety of her…

Read More

One day at an Idaho hospital, half the newborns Dr. Tom Patterson saw didn’t get the vitamin K shots that have been given to babies for decades to prevent potentially deadly bleeding. On another recent day, more than a quarter didn’t get the shot. Their parents wouldn’t allow it.“When you look at a child who’s innocent and vulnerable — and a simple intervention that’s been done since 1961 is refused — knowing that baby’s going out into the world is super worrisome to me,” said Patterson, who’s been a pediatrician for nearly three decades.Doctors across the nation are alarmed that…

Read More

It’s an anniversary no one wants to celebrate, but an anniversary nonetheless.Thursday, March 19, marked six years since the first COVID-19 lockdown was implemented in the United States. And while it is undeniable that the impact of the global pandemic is still felt worldwide, one place Americans see its lingering effects the most is in vaccine policy.Vaccine hesitancy surged after the FDA approved the first COVID vaccine in August 2021. Since then, it has only bolstered following the appointment of Health and Human Services Secretary Robert F. Kennedy Jr., a known vaccine skeptic, early in Trump’s second administration.The Trump administration’s ensuing…

Read More

OpenAI has built one of the most popular products in the world. Now it has to figure out how to pay for it.Enter Fidji Simo.Simo, the 40-year-old former Instacart CEO and longtime Meta executive, became OpenAI’s product boss in August under CEO Sam Altman. While Altman has long been the face of OpenAI, Simo is increasingly shaping how the company operates and makes money.”Part of bringing me on, and giving me the responsibilities of a CEO, was to make sure that I could really run that part of the company with autonomy,” Simo, whose title is CEO of applications, told…

Read More

Nearly five years ago, Mark Zuckerberg told us the future was the metaverse — an idea that seemed to involve all of us strapping on virtual reality goggles and interacting with digital versions of ourselves. Loading audio narration… Now, reports say Zuckerberg’s Meta is bailing on the metaverse after losing more than $80 billion on the project.This is a fun story for people who like stories about Big Tech tripping on itself.But it’s not really true.Start with the $80 billion that publications like The New York Times and others say Zuckerberg has lost chasing the metaverse. Meta has indeed generated…

Read More

Plenty of companies are still debating whether costly AI subscriptions are worth it. Miro has gone the other way. Loading audio narration… Andrey Khusid, cofounder of Miro, the maker of a popular online whiteboard platform, says the company gives employees essentially unlimited access to the latest AI tools as a way to speed up how quickly they learn and work.That approach is possible, he said, because Miro has been profitable since 2016. The company has raised $476 million to date, and Khusid suggested it does not expect to need more capital.Khusid framed the spending as a core part of more…

Read More

During her first year of college, Elisabeth Bradley was inspired to try weightlifting after she followed a woman tracking her fitness transformation on social media, one barbell at a time.Then, Bradley found herself to be the only woman in the weight room at San Diego State University.“I felt like I stuck out a lot, and I just thought, ‘OK, I’m gonna look dumb,’” she says. Intimidated by a room full of grunting, muscular men, she moved over to the cardio area, mirroring countless women who, for various reasons, avoid the free weights and machines.But with research mounting on the benefits…

Read More

Anthropic submitted two sworn declarations to a California federal court late Friday afternoon, pushing back on the Pentagon’s assertion that the AI company poses an “unacceptable risk to national security” and arguing that the government’s case relies on technical misunderstandings and claims that were never actually raised during the months of negotiations that preceded the dispute. The declarations were filed alongside Anthropic’s reply brief in its lawsuit against the Department of Defense and come ahead of a hearing this coming Tuesday, March 24, before Judge Rita Lin in San Francisco. The dispute traces back to late February, when President Trump…

Read More

A jury on Friday found that Elon Musk’s complaints about bots on Twitter ahead of his purchase of the site were intentionally misleading to shareholders. Loading audio narration… The jury in Musk’s San Francisco securities fraud trial unanimously found him liable for making two misleading statements in the run-up to his 2022 acquisition of the social media site. They rejected two other fraud claims.The jury calculated how much Musk’s complaints about bots on Twitter affected the company’s share price before his acquisition, tracking five months of stock activity that showed a steep drop off after his comments. The jury found…

Read More

The White House said Friday it’s adding three drugs for diabetes and lung disease to the self-pay platform TrumpRx, as the administration works to expand the site as part of its push to lower drug prices.The drugs, from German drugmaker Boehringer Ingelheim, are Jentadueto and Jentadueto XR, for Type 2 diabetes, as well as the COPD drug Striverdi Respimat.According to the White House, the diabetes drugs list for about $525 but are priced on TrumpRx starting around $55, while the COPD drug is listed at about $35, down from roughly $276.One of the diabetes drugs, Jentadueto, has a generic version…

Read More